Trial NCT00492531

View at ClinicalTrials.gov 
Org. Study IDs: 070177
Secondary IDs: 07-H-0177

Last trial update was posted on 2016-01-06

MeSH Interventions

Phosphodiesterase 5 Inhibitors Sildenafil Citrate

MeSH Conditions

Anemia, Sickle Cell Hypertension Hypertension, Pulmonary

Other Conditions

Pulmonary Hypertension Sickle Cell Disease

Stopping Reasons

Subjects on drug were more likely to have severe pain crises requiring hospitalization.

Limitations And Caveats

As a result of early termination due to safety findings, the study was underpowered to assess the effects of sildenafil therapy on the predetermined efficacy endpoints.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID